| James Leslie Stribling, MD | |
|
4453 Mallard Pt, Columbus, IN 47201-8807 | |
| (812) 342-6637 | |
| Not Available |
| Full Name | James Leslie Stribling |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 4453 Mallard Pt, Columbus, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639320922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 01019124 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Leslie Stribling, MD 4453 Mallard Pt, Columbus, IN 47201-8807 Ph: (812) 342-6637 | James Leslie Stribling, MD 4453 Mallard Pt, Columbus, IN 47201-8807 Ph: (812) 342-6637 |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.
A team of researchers at The University of Kansas Cancer Center have been awarded a five-year, $1.8 million grant from the National Institutes of Health to study chronic inflammation of the liver, a major factor in the development of liver cancer.
Radiotherapy after breast conserving surgery has been shown to reduce the risk of breast cancer recurrence. However, although younger women tend to have more aggressive tumors and have higher risks of recurrence than older BC patients, they are less likely to receive RT after BCS, according to a study published December 24 in the Journal of the National Cancer Institute. Although treatment patterns among older BC patients have been well-studied, factors affecting non-compliance among younger women are not well-known.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, Inc., has been granted orphan-drug designation by the U.S. Food and Drug Administration for perifosine, Aeterna Zentaris' novel, potentially first-in-class, oral Akt inhibitor, for the treatment of neuroblastoma.
› Verified 8 days ago
Dr. William D Jones, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3183 N National Rd, Columbus, IN 47201 Phone: 812-372-1581 Fax: 812-376-4028 | |
Mr. Daniel H Davis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2450 Northpark Dr Ste A, Columbus, IN 47203 Phone: 812-376-3311 Fax: 812-376-4125 | |
Rolf C Loescher, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-372-1581 | |
Dr. Karen Leigh Dorough, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1405 Washington St, Columbus, IN 47201 Phone: 812-375-1550 Fax: 812-375-1581 | |
Jacob Venesky, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2114 25th St Ste A, Columbus, IN 47201 Phone: 812-372-1581 | |
Cheryl A Conetsco, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2326 18th St, Ste 210, Columbus, IN 47201 Phone: 812-372-8426 Fax: 812-372-8301 | |
Betsy Place, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2450 Northpark Dr Ste A, Columbus, IN 47203 Phone: 812-376-3311 |